Position in VRTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$29,330,533
+$7,769,185 QoQ
Shares Held
65,684
+38.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$40,270
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $268,759,923 across 111 Biotechnology names. VRTX ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,200 | $58,503,546 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
58,925 | $45,527,812 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,859 | $35,025,567 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
65,684 | $29,330,533 | |
| 5 | RPRX |
Royalty Pharma plc
|
292,921 | $14,051,420 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
56,633 | $9,572,109 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
146,462 | $9,183,167 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
13,914 | $7,283,561 |
All Filings in VRTX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,330,533 | 65,684 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $21,561,348 | 47,559 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $17,238,034 | 44,015 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $25,085,684 | 56,347 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $25,998,472 | 53,625 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $40,270 | 100 | Put | Sole | 2025-02-07 | |
| 2024-12-31 | $19,565,582 | 48,586 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $26,622,109 | 57,242 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $46,872 | 100 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $24,886,219 | 53,094 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $23,946,120 | 57,286 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $33,547,673 | 82,449 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $30,772,903 | 88,494 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $29,539,677 | 83,941 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,507 | 100 | Call | Sole | 2023-05-12 | |
| 2023-03-31 | $19,226,516 | 61,023 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,432,249 | 63,828 | Shares | Sole | 2023-02-09 | |
| 2022-12-31 | $288 | 1 | Put | Sole | 2023-02-09 | |
| 2022-09-30 | $289 | 1 | Put | Sole | 2022-11-09 | |
| 2022-09-30 | $14,465,128 | 49,959 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $16,289,434 | 57,807 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $24,611,819 | 94,309 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $14,243,914 | 64,863 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,733,024 | 53,658 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,698,615 | 13,384 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,359,805 | 15,635 | Shares | Sole | 2021-05-10 | |
| 2020-09-30 | $3,587,902 | 13,185 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $203,217 | 700 | Call | Sole | 2020-08-10 | |
| 2020-06-30 | $3,303,437 | 11,379 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,372,123 | 9,969 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||